Tinnitus Treatment: What Actually Helps (and What Doesn't)

Hearing aids and sound therapy: the first line of treatment

For people with tinnitus and even mild hearing loss, hearing aids are often the first thing an audiologist recommends, and for good reason. Amplifying external sound restores input to the affected frequency range, which reduces the brain's compensatory internal gain, the same mechanism that produces tinnitus in the first place. Many modern hearing aids also include a built-in masking feature: a soft, customizable sound layered under everyday listening that takes the edge off the ringing without eliminating outside sound.

Sound therapy on its own, without hearing aids, works on a similar principle. White noise machines, fan noise, nature sound apps, and dedicated tinnitus maskers introduce a steady external sound that competes with the internal signal for attention. It doesn't cure tinnitus, but for many people it makes the difference between a background irritation and something that dominates a quiet room.

Neither approach works instantly. Most people need several weeks of consistent use before they notice a meaningful shift in how intrusive the tinnitus feels.

Cognitive behavioral therapy and tinnitus retraining therapy

Cognitive behavioral therapy (CBT) and tinnitus retraining therapy (TRT) are the two most evidence-supported structured treatments for tinnitus that's genuinely distressing. Neither changes the sound itself. Both change how much attention and emotional weight the brain assigns to it, which for many people matters more than the sound's volume.

CBT, delivered by a therapist trained in tinnitus management, targets the anxiety and catastrophizing that often build around chronic ringing: the fear that it will get worse, the frustration of not being able to escape it, the sleep disruption that follows. TRT combines counseling with structured sound therapy over months, aiming to retrain the brain to treat the tinnitus signal as unimportant background noise, the way it already does with the sound of your own breathing.

Both require a trained provider and real time investment. Neither is a quick fix, but both have decades of research behind them and are standard recommendations from audiologists who specialize in tinnitus.

Lenire: an FDA-cleared device for bimodal neuromodulation

In March 2023, the FDA granted De Novo authorization to Lenire, a device made by Neuromod Devices, making it the first tinnitus treatment device cleared through that pathway. Lenire works through what's called bimodal neuromodulation: it delivers mild electrical pulses to the tongue at the same time it plays sound through headphones, a combination designed to retrain the brainstem circuits involved in how tinnitus is generated and perceived.

The clearance was based on Neuromod's TENT-A3 trial, the company's third large-scale study. Across the full trial population, 79.4% of participants reported a clinically meaningful improvement in tinnitus symptoms, and 88.6% said they would recommend the device to another person with tinnitus. That's a notably strong result for a tinnitus intervention, though it's still device-specific evidence from trials the manufacturer sponsored, not an independent long-term consensus.

Lenire is a prescription device. It isn't sold directly to consumers: it requires an audiologist or ENT to evaluate your tinnitus, fit the device, and set your treatment parameters, followed by a home-use program (typically twice-daily sessions over several weeks). As of 2026, self-pay treatment programs typically run $3,850 to $4,500, covering the device, evaluation, fitting, and follow-up care. Most private insurance doesn't cover it, though it became available to US veterans through the VA in 2024.

It's a genuine option worth asking about, not a guaranteed fix. Like every tinnitus treatment on this list, it works for many people and not for everyone, and it still requires a clinical relationship to access.

What doesn't help (and can waste your money)

Tinnitus is uncomfortable enough that it attracts a steady stream of products promising a cure: supplements, essential oils, unregulated "tinnitus relief" apps, and devices sold with no clinical trial behind them at all. Ginkgo biloba, one of the most commonly marketed tinnitus supplements, is a good example of why it pays to look closely. A 2022 Cochrane review found the existing trials too small and inconsistently designed to support using it, rating the evidence as low to very low certainty.

The general rule is simple: if a product promises to eliminate tinnitus entirely, cites no published clinical trial, or is sold with no clinician involved, treat the claim with real skepticism. The treatments with genuine evidence behind them, hearing aids, structured sound therapy, CBT, TRT, and Lenire, all involve a professional evaluation at some point. That's not a coincidence. Tinnitus has enough individual variation that what helps one person do little for another, and a real evaluation is what identifies which path fits your situation.